PD-L1/PD-1 In Hepatocellular Carcinoma: An Institutional Review

被引：0
|
作者：
Poveda, Julio [1 ]
Duarte, Melissa [2 ]
Jones, Patricia Denise [1 ]
Chowdhury, Aneesa [1 ]
Brown, Kevin [1 ]
Garcia-Buitrago, Monica [3 ]
机构：
[1] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[2] Univ Miami, Jackson Hlth Syst, Miami, FL USA
[3] Univ Miami, Miller Sch Med, Jackson Hlth Syst, Miami, FL 33136 USA
来源：
MODERN PATHOLOGY | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1556
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PD-L1/PD-1 In Hepatocellular Carcinoma: An Institutional Review
    Poveda, Julio
    Duarte, Melissa
    Jones, Patricia Denise
    Chowdhury, Aneesa
    Brown, Kevin
    Garcia-Buitrago, Monica
    LABORATORY INVESTIGATION, 2019, 99
  • [2] POTENTIAL AS BIOMARKERS OF SOLUBLE PD-1 AND PD-L1 IN HEPATOCELLULAR CARCINOMA
    Kanzaki, Hiroaki
    Chiba, Tetsuhiro
    Kato, Naoya
    HEPATOLOGY, 2019, 70 : 1218A - 1218A
  • [3] Clinical outcomes and influencing factors of PD-1/PD-L1 in hepatocellular carcinoma
    Wang, Jiting
    Li, Jun
    Tang, Guiju
    Tian, Yuan
    Su, Song
    Li, Yaling
    ONCOLOGY LETTERS, 2021, 21 (04) : 1 - 8
  • [4] PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy
    Li, Qian
    Han, Jingjing
    Yang, Yonglin
    Chen, Yu
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [5] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
    Bai, Jie
    Gao, Zhitao
    Li, Xiang
    Dong, Liang
    Han, Weidong
    Nie, Jing
    ONCOTARGET, 2017, 8 (66) : 110693 - 110707
  • [6] INTRATUMORAL EXPRESSION OF PD-1/PD-L1 IMMUNE CHECKPOINT IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Baquerizo, Angeles
    Vavinskaya, Vera
    Rojas, Angela
    Mhoyan, Anna
    Romero-Gomez, Manuel
    Sher, Linda
    Madani, Bahar
    Fisher, Jonathan
    Schaffer, Randolph
    Frenette, Catherine T.
    Marsh, Christopher
    HEPATOLOGY, 2019, 70 : 206A - 206A
  • [7] Measurement of soluble PD-1 and soluble PD-L1 as well as PD-L1 and PD-1 from perioperative patients with gastric carcinoma
    Wei, Hangzhi
    Wu, Fahong
    Mao, Yudong
    Zhang, Youcheng
    Leng, Guangxian
    Wang, Jia
    Zhang, Wei
    Wang, Tianwei
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (04) : 331 - 345
  • [8] Efficacy of PD-1/PD-L1 inhibitors in advanced hepatocellular carcinoma: A systematic review and meta-analysis
    Peng, Tzu-Rong
    Yang, Li-Jou
    Wu, Ta-Wei
    TZU CHI MEDICAL JOURNAL, 2024, 36 (03): : 340 - 348
  • [9] Targeting the PD-1/PD-L1 interaction in nasopharyngeal carcinoma
    Johnson, David
    Ma, Brigette B. Y.
    ORAL ONCOLOGY, 2021, 113
  • [10] The predictive value of PD-L1 expression in patients with advanced hepatocellular carcinoma treated with PD-1/PD-L1 inhibitors: A systematic review and meta-analysis
    Yang, Yao
    Chen, Dongbo
    Zhao, Bigeng
    Ren, Liying
    Huang, Rui
    Feng, Bo
    Chen, Hongsong
    CANCER MEDICINE, 2023, 12 (08): : 9282 - 9292
12345